Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04893551
Title A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors BerGenBio ASA
Age Groups: adult | senior
Covered Countries GBR

No variant requirements are available.